OTCMKTS:IPATF

ImmunoPrecise Antibodies (IPATF) Stock Price, News & Analysis

ImmunoPrecise Antibodies logo
$0.80 -0.10 (-11.30%)
As of 11/19/2026

About ImmunoPrecise Antibodies Stock (OTCMKTS:IPATF)

Advanced

Key Stats

Today's Range
$0.78
▼
$0.96
50-Day Range
$0.99
▼
$1.50
52-Week Range
$1.15
▼
$20.25
Volume
416,425 shs
Average Volume
20,327 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ImmunoPrecise Antibodies Ltd. is a biotechnology company that provides antibody discovery and development services to pharmaceutical and biotechnology companies, academic institutions, and other research organizations. Its work supports the development of antibody-based therapeutics and diagnostics.

The company offers services spanning antibody discovery, engineering, optimization, production, and characterization. Its approaches include animal-based and in vitro discovery methods, as well as computational tools intended to support antibody research and development.

Based in Canada, ImmunoPrecise operates through a network of research and service locations in North America and Europe. Its business combines laboratory-based antibody expertise with computational capabilities to help clients advance biologic drug candidates.

AI Generated. May Contain Errors.

Receive IPATF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IPATF Stock News Headlines

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Up 6% - Still a Buy?
Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
ImmunoPrecise Antibodies: Q2 Earnings Insights
See More Headlines

IPATF Stock Analysis - Frequently Asked Questions

ImmunoPrecise Antibodies' stock was trading at $1.70 on January 1st, 2026. Since then, IPATF stock has decreased by 53.0% and is now trading at $0.7983.

Shares of IPATF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
OTCMKTS:IPATF
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (OTCMKTS:IPATF) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners